The overall recommendations, clinical pharmacology, pharmacokinetics and key drug-drug interactions for each the eight most-commonly used kinase inhibitors for key tumour types are shown below. Further information on each aspect can be found by clicking on each kinase inhibitor:

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings